Literature DB >> 12586738

The p54 cleaved form of the tyrosine kinase Lyn generated by caspases during BCR-induced cell death in B lymphoma acts as a negative regulator of apoptosis.

Frederic Luciano1, Magali Herrant, Arnaud Jacquel, Jean-Ehrland Ricci, Patrick Auberger.   

Abstract

Engagement of the B cell receptor antigen (BCR) triggers apoptosis on immature B cell lines. We report here that BCR triggering leads to caspase activation followed by Lyn cleavage and induction of apoptosis. The cleavage process is mitochondrion-dependent and involves caspases 9 and 7. Stable expression of the cleaved form of Lyn (Lyn-Delta-N) in Ramos B cells impairs BCR-mediated apoptosis as judged by loss of Delta(psi)m, caspase activation and PARP cleavage. Activation of the main survival pathways upon BCR-triggering was unaltered in both cell variants. However, the PI3-K inhibitor Ly294002 resensitizes Lyn-Delta-N cells to apoptosis. Selected cDNA expression arrays revealed that anti-IgM modulates the expression of approximately 20 genes in both cell variants. Among them, only c-Myc was found to be differentially regulated, which suggests a role for c-Myc in the B cell apoptotic response. Interestingly, c-Myc expression decreased more rapidly in Lyn-Delta-N compared with Lyn-WT cells during the first hours of anti-IgM stimulation. Nevertheless, rapid down-regulation of c-Myc following BCR engagement seems to correlate with the resistance of B cells to apoptosis. Thus, the soluble form of Lyn generated by caspases following BCR triggering acts as an inhibitor of B lymphocyte death likely through the modulation of c-Myc expression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12586738     DOI: 10.1096/fj.02-0716fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  14 in total

1.  Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157.

Authors:  Jiang-Yan Yang; Joël Walicki; David Michod; Gilles Dubuis; Christian Widmann
Journal:  Mol Biol Cell       Date:  2005-05-18       Impact factor: 4.138

Review 2.  Physiological functions and clinical implications of the N-end rule pathway.

Authors:  Yujiao Liu; Chao Liu; Wen Dong; Wei Li
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

3.  The oncogenic tyrosine kinase Lyn impairs the pro-apoptotic function of Bim.

Authors:  Lazaro E Aira; Elodie Villa; Pascal Colosetti; Parvati Gamas; Laurie Signetti; Sandrine Obba; Emma Proics; Fabien Gautier; Béatrice Bailly-Maitre; Arnaud Jacquel; Guillaume Robert; Frédéric Luciano; Philippe P Juin; Jean-Ehrland Ricci; Patrick Auberger; Sandrine Marchetti
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

4.  The caspase-cleaved form of LYN mediates a psoriasis-like inflammatory syndrome in mice.

Authors:  Sandrine Marchetti; Parvati Gamas; Nathalie Belhacène; Sebastien Grosso; Ludivine A Pradelli; Pascal Colosetti; Claus Johansen; Lars Iversen; Marcel Deckert; Fréderic Luciano; Paul Hofman; Nicolas Ortonne; Abdallah Khemis; Bernard Mari; Jean-Paul Ortonne; Jean-Ehrland Ricci; Patrick Auberger
Journal:  EMBO J       Date:  2009-07-09       Impact factor: 11.598

5.  Caspase-3 protects stressed organs against cell death.

Authors:  Hadi Khalil; Nieves Peltzer; Joël Walicki; Jiang-Yan Yang; Gilles Dubuis; Noémie Gardiol; Werner Held; Paul Bigliardi; Benjamin Marsland; Lucas Liaudet; Christian Widmann
Journal:  Mol Cell Biol       Date:  2012-09-04       Impact factor: 4.272

6.  Functions of the Lyn tyrosine kinase in health and disease.

Authors:  Evan Ingley
Journal:  Cell Commun Signal       Date:  2012-07-17       Impact factor: 5.712

7.  The anti-apoptotic form of tyrosine kinase Lyn that is generated by proteolysis is degraded by the N-end rule pathway.

Authors:  Mohamed A Eldeeb; Richard P Fahlman
Journal:  Oncotarget       Date:  2014-05-15

8.  Severe thymic atrophy in a mouse model of skin inflammation accounts for impaired TNFR1 signaling.

Authors:  Nathalie Belhacéne; Parvati Gamas; Diogo Gonçalvès; Marie Jacquin; Marie Beneteau; Arnaud Jacquel; Pascal Colosetti; Jean-Ehrland Ricci; Abdellilah Wakkach; Patrick Auberger; Sandrine Marchetti
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.

Authors:  Jens O Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  PLoS One       Date:  2013-02-01       Impact factor: 3.240

10.  The necrotic signal induced by mycophenolic acid overcomes apoptosis-resistance in tumor cells.

Authors:  Gwendaline Guidicelli; Benjamin Chaigne-Delalande; Marie-Sarah Dilhuydy; Benoît Pinson; Walid Mahfouf; Jean-Max Pasquet; François-Xavier Mahon; Philippe Pourquier; Jean-François Moreau; Patrick Legembre
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.